rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2008-2-13
|
pubmed:abstractText |
Oral lichen planus (OLP) is considered to be an autoimmune disease of unknown aetiology that affects the mucosae, especially the oral cavity. Objective: We compared tacrolimus 0.1% ointment and clobetasol 0.05% ointment for the treatment of OLP.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
D
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1600-051X
|
pubmed:author |
pubmed-author:BambaraLisa MariaLM,
pubmed-author:BiasiDomenicoD,
pubmed-author:CorrocherGiovanniG,
pubmed-author:CorrocherRobertoR,
pubmed-author:Di LorenzoGabrieleG,
pubmed-author:FiorAndreaA,
pubmed-author:GelioStefanoS,
pubmed-author:LombardoGiorgioG,
pubmed-author:MansuetoPasqualeP,
pubmed-author:MartinelliNicolaN,
pubmed-author:NociniPier FrancescoPF,
pubmed-author:PacorMaria LuisaML
|
pubmed:issnType |
Electronic
|
pubmed:volume |
35
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
244-9
|
pubmed:meshHeading |
pubmed-meshheading:18269664-Adult,
pubmed-meshheading:18269664-Anti-Inflammatory Agents,
pubmed-meshheading:18269664-Clobetasol,
pubmed-meshheading:18269664-Epidemiologic Methods,
pubmed-meshheading:18269664-Facial Pain,
pubmed-meshheading:18269664-Female,
pubmed-meshheading:18269664-Humans,
pubmed-meshheading:18269664-Immunosuppressive Agents,
pubmed-meshheading:18269664-Lichen Planus, Oral,
pubmed-meshheading:18269664-Male,
pubmed-meshheading:18269664-Ointment Bases,
pubmed-meshheading:18269664-Saliva,
pubmed-meshheading:18269664-Tacrolimus
|
pubmed:year |
2008
|
pubmed:articleTitle |
Comparative effect of tacrolimus 0.1% ointment and clobetasol 0.05% ointment in patients with oral lichen planus.
|
pubmed:affiliation |
Dipartimento di Scienze Morfologico-Biomediche, Sezione di Chirurgia Maxillo-Faciale e Odontostomatologia, Università di Verona, Verona, Italy.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|